Open App →
Back to News Feed
PR Newswire November 19, 2026 neutral

Isomorphic Labs and MSD Enter Strategic Research Collaboration

AI / LLM
<p>LONDON, Nov. 19, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, and MSD, trade name of Merck & Co., Inc., Rahway, NJ, USA, today announced a research collaboration that brings together Isomorphic Labs' AI approach to drug discovery with MSD's rich...</p>
Read original article ↗

Related Articles

New Taipei City candidate released on bail

Taipei Times · November 20, 2026

Taipei certifies Japanese-era artifacts from schools

Taipei Times · November 20, 2026

Trump unlikely to concede on Taiwan: academics

Taipei Times · November 20, 2026

Two damaged Taichung MRT cars to be auctioned off

Taipei Times · November 20, 2026